Industry Research Reports

Home > Reports > Medical Devices & Consumables > Knee Denervation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Knee Denervation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-01-05

Pages: 104 Pages

Report ld: 5514797

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Knee Denervation Market Size(US$)

CAGR 2026-2032

20.3%

Market Size,2032

USD 1,482

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 489 million

Market Forecast in 2032(Value)

US$ 1,482 million

CAGR

20.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Knee Denervation was estimated to be worth US$ 413 million in 2025 and is projected to reach US$ 1482 million, growing at a CAGR of 20.3% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Knee Denervation cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Knee denervation is a minimally invasive medical procedure designed to reduce chronic knee pain, typically in patients with osteoarthritis or persistent pain following knee surgeries, such as knee replacements. The procedure involves selectively interrupting the sensory nerves that transmit pain signals from the knee to the brain. This is achieved without affecting motor function, thereby preserving joint movement.

Osteoarthritis (OA) is a degenerative disease common in synovial joints, which can cause degeneration of articular cartilage, bone hyperplasia at the joint margin and under the cartilage, etc. Knee osteoarthritis (KOA) is the most common knee disease in the limb joints. Domestic statistics show that more than 3% of people in my country suffer from OA, and KOA accounts for the majority. As my country gradually enters an aging society, the incidence of KOA is higher in the population. According to relevant data, the incidence rate in people over 60 years old is as high as 12%, and it is increasing with age.

KOA is essentially a degenerative disease and cannot be cured clinically. At present, KOA patients mostly use conservative treatments such as physical therapy, analgesics and intra-articular injections to control pain and improve their quality of life. Before drug intervention, there are auxiliary treatment measures such as physical therapy, exercise, and weight loss. It is generally believed that anti-inflammatory analgesics are the first choice for the treatment of KOA, but long-term use often produces adverse reactions. Intra-articular injection of glucocorticoids or sodium hyaluronate is believed to relieve inflammation in the joint and promote cartilage repair. Repeated injections can maintain the efficacy, but the effect will still decline after several years. Total knee arthroplasty (TKA) surgery is considered to be the only effective ultimate solution, but some patients still have poor postoperative effects or long-term postoperative pain. The urgent need for pain treatment in KOA patients has given rise to the application of Knee Denervation technology in this field.

Knee Denervation includes traditional radiofrequency ablation (RFA), pulsed radiofrequency (PRF), cooled RFA (CRF) and laser treatment. The principles, parameters and efficacy of Knee Denervation technology are still in the early stages, which leads to large differences in the technical methods used by different research teams. However, through a systematic evaluation of numerous clinical trials and case reports, it can still be concluded that Knee Denervation can relieve pain and improve quality of life for up to about 1 year in the treatment of postoperative pain after KOA or TKA, and has the advantages of less trauma and fewer complications.

According to our data, the global volume of Knee Denervation surgeries will be around 130,000 in 2024, and the volume is expected to reach 155,000 in 2025. The compound annual growth rate of Knee Denervation will reach more than 15% in the next five years, and the market size will exceed US$100 million by 2030. From a regional perspective, North America occupies a major position in the Knee Denervation industry with its complete medical facilities and advanced technology, with a market share of nearly 50% in 2024, followed by Europe and Asia Pacific. From a technical point of view, the main method of Knee Denervation is radiofrequency ablation, which will account for more than 90% in 2024, but laser therapy (invasive LA) and other methods are gradually showing their advantages and are developing rapidly.

With the extension of life expectancy, the health problems caused by degenerative diseases will inevitably become a major health threat. The knee joint is an important load-bearing joint in the human body. Chronic pain, especially KOA, will seriously reduce the quality of life of patients. Patients with moderate to severe or refractory KOA benefit less from traditional treatments and have to endure many adverse reactions. TKA surgery can only solve the problems of some patients. Some patients still have poor surgical results or do not have the conditions for surgical treatment. Knee Denervation for pain treatment has shown good therapeutic effects and high safety, and has huge market potential in the future.

This report provides a comprehensive view of the global market for Knee Denervation, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Knee Denervation market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Knee Denervation.

MARKET SEGMENTATION

By Company

Boston Scientific
Stryker
Abbott
Avanos Medical (coolief)
Cosman Medical
Diros Technology
Vantage MedTech
STARmed America
Beijing Neo Science

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Standard RFA
Cooled RFA
Others

Segment by Application

Hospital
Clinic

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Knee Denervation manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Knee Denervation sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Knee Denervation sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Knee Denervation Product Introduction

1.2 Global Knee Denervation Market Size Forecast

1.2.1 Global Knee Denervation Sales Value (2021–2032)

1.2.2 Global Knee Denervation Sales Volume (2021–2032)

1.2.3 Global Knee Denervation Sales Price (2021–2032)

1.3 Knee Denervation Market Trends & Drivers

1.3.1 Knee Denervation Industry Trends

1.3.2 Knee Denervation Market Drivers & Opportunities

1.3.3 Knee Denervation Market Challenges

1.3.4 Knee Denervation Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Knee Denervation Players Revenue Ranking (2025)

2.2 Global Knee Denervation Revenue by Company (2021–2026)

2.3 Global Knee Denervation Sales Volume Ranking of Players (2025)

2.4 Global Knee Denervation Sales Volume by Company (2021–2026)

2.5 Global Knee Denervation Average Price by Company (2021–2026)

2.6 Key Manufacturers Knee Denervation Manufacturing Base and Headquarters

2.7 Key Manufacturers Knee Denervation Product Offerings

2.8 Key Manufacturers Start of Mass Production of Knee Denervation

2.9 Knee Denervation Market Competitive Analysis

2.9.1 Knee Denervation Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Knee Denervation Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Knee Denervation revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Knee Denervation Market Classification

3.1 Introduction by Type

3.1.1 Standard RFA

3.1.2 Cooled RFA

3.1.3 Others

3.1.4 Global Knee Denervation Sales Value by Type

3.1.4.1 Global Knee Denervation Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Knee Denervation Sales Value, by Type (2021–2032)

3.1.4.3 Global Knee Denervation Sales Value, by Type (%), 2021–2032

3.1.5 Global Knee Denervation Sales Volume by Type

3.1.5.1 Global Knee Denervation Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Knee Denervation Sales Volume, by Type (2021–2032)

3.1.5.3 Global Knee Denervation Sales Volume, by Type (%), 2021–2032

3.1.6 Global Knee Denervation Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.2 Global Knee Denervation Sales Value by Application

4.2.1 Global Knee Denervation Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Knee Denervation Sales Value, by Application (2021–2032)

4.2.3 Global Knee Denervation Sales Value, by Application (%), 2021–2032

4.3 Global Knee Denervation Sales Volume by Application

4.3.1 Global Knee Denervation Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Knee Denervation Sales Volume, by Application (2021–2032)

4.3.3 Global Knee Denervation Sales Volume, by Application (%), 2021–2032

4.4 Global Knee Denervation Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Knee Denervation Sales Value by Region

5.1.1 Global Knee Denervation Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Knee Denervation Sales Value by Region (2021–2026)

5.1.3 Global Knee Denervation Sales Value by Region (2027–2032)

5.1.4 Global Knee Denervation Sales Value by Region (%), 2021–2032

5.2 Global Knee Denervation Sales Volume by Region

5.2.1 Global Knee Denervation Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Knee Denervation Sales Volume by Region (2021–2026)

5.2.3 Global Knee Denervation Sales Volume by Region (2027–2032)

5.2.4 Global Knee Denervation Sales Volume by Region (%), 2021–2032

5.3 Global Knee Denervation Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Knee Denervation Sales Value, 2021–2032

5.4.2 North America Knee Denervation Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Knee Denervation Sales Value, 2021–2032

5.5.2 Europe Knee Denervation Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Knee Denervation Sales Value, 2021–2032

5.6.2 Asia Pacific Knee Denervation Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Knee Denervation Sales Value, 2021–2032

5.7.2 South America Knee Denervation Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Knee Denervation Sales Value, 2021–2032

5.8.2 Middle East & Africa Knee Denervation Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Knee Denervation Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Knee Denervation Sales Value and Sales Volume

6.2.1 Key Countries/Regions Knee Denervation Sales Value, 2021–2032

6.2.2 Key Countries/Regions Knee Denervation Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Knee Denervation Sales Value, 2021–2032

6.3.2 United States Knee Denervation Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Knee Denervation Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Knee Denervation Sales Value, 2021–2032

6.4.2 Europe Knee Denervation Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Knee Denervation Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Knee Denervation Sales Value, 2021–2032

6.5.2 China Knee Denervation Sales Value by Type (%), 2025 vs 2032

6.5.3 China Knee Denervation Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Knee Denervation Sales Value, 2021–2032

6.6.2 Japan Knee Denervation Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Knee Denervation Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Knee Denervation Sales Value, 2021–2032

6.7.2 South Korea Knee Denervation Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Knee Denervation Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Knee Denervation Sales Value, 2021–2032

6.8.2 Southeast Asia Knee Denervation Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Knee Denervation Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Knee Denervation Sales Value, 2021–2032

6.9.2 India Knee Denervation Sales Value by Type (%), 2025 vs 2032

6.9.3 India Knee Denervation Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Boston Scientific

7.1.1 Boston Scientific Company Information

7.1.2 Boston Scientific Introduction and Business Overview

7.1.3 Boston Scientific Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Boston Scientific Knee Denervation Product Offerings

7.1.5 Boston Scientific Recent Developments

7.2 Stryker

7.2.1 Stryker Company Information

7.2.2 Stryker Introduction and Business Overview

7.2.3 Stryker Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Stryker Knee Denervation Product Offerings

7.2.5 Stryker Recent Developments

7.3 Abbott

7.3.1 Abbott Company Information

7.3.2 Abbott Introduction and Business Overview

7.3.3 Abbott Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Abbott Knee Denervation Product Offerings

7.3.5 Abbott Recent Developments

7.4 Avanos Medical (coolief)

7.4.1 Avanos Medical (coolief) Company Information

7.4.2 Avanos Medical (coolief) Introduction and Business Overview

7.4.3 Avanos Medical (coolief) Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Avanos Medical (coolief) Knee Denervation Product Offerings

7.4.5 Avanos Medical (coolief) Recent Developments

7.5 Cosman Medical

7.5.1 Cosman Medical Company Information

7.5.2 Cosman Medical Introduction and Business Overview

7.5.3 Cosman Medical Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Cosman Medical Knee Denervation Product Offerings

7.5.5 Cosman Medical Recent Developments

7.6 Diros Technology

7.6.1 Diros Technology Company Information

7.6.2 Diros Technology Introduction and Business Overview

7.6.3 Diros Technology Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Diros Technology Knee Denervation Product Offerings

7.6.5 Diros Technology Recent Developments

7.7 Vantage MedTech

7.7.1 Vantage MedTech Company Information

7.7.2 Vantage MedTech Introduction and Business Overview

7.7.3 Vantage MedTech Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Vantage MedTech Knee Denervation Product Offerings

7.7.5 Vantage MedTech Recent Developments

7.8 STARmed America

7.8.1 STARmed America Company Information

7.8.2 STARmed America Introduction and Business Overview

7.8.3 STARmed America Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 STARmed America Knee Denervation Product Offerings

7.8.5 STARmed America Recent Developments

7.9 Beijing Neo Science

7.9.1 Beijing Neo Science Company Information

7.9.2 Beijing Neo Science Introduction and Business Overview

7.9.3 Beijing Neo Science Knee Denervation Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 Beijing Neo Science Knee Denervation Product Offerings

7.9.5 Beijing Neo Science Recent Developments

8 Industry Chain Analysis

8.1 Knee Denervation Industrial Chain

8.2 Knee Denervation Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Knee Denervation Sales Model

8.5.2 Sales Channels

8.5.3 Knee Denervation Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Knee Denervation Market Trends

Table 2. Knee Denervation Market Drivers & Opportunities

Table 3. Knee Denervation Market Challenges

Table 4. Knee Denervation Market Restraints

List of Figures

Figure 1. Knee Denervation Product Picture

Figure 2. Global Knee Denervation Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 4. Global Knee Denervation Sales Volume (Units), 2021–2032

Figure 5. Global Knee Denervation Sales Price (US$/Unit), 2021–2032

Figure 6. Knee Denervation Report Years Considered

Figure 7. Global Knee Denervation Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Knee Denervation Sales Volume Ranking of Players (Units), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Knee Denervation Revenue in 2025

Figure 10. Knee Denervation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Standard RFA Picture

Figure 12. Cooled RFA Picture

Figure 13. Others Picture

Figure 14. Global Knee Denervation Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Knee Denervation Sales Value Market Share by Type, 2025 & 2032

Figure 16. Global Knee Denervation Sales Volume by Type (Units), 2021 vs 2025 vs 2032

Figure 17. Global Knee Denervation Sales Volume Market Share by Type, 2025 & 2032

Figure 18. Global Knee Denervation Price by Type (US$/Unit), 2021–2032

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Clinic

Figure 21. Global Knee Denervation Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Knee Denervation Sales Value Market Share by Application, 2025 & 2032

Figure 23. Global Knee Denervation Sales Volume by Application (Units), 2021 vs 2025 vs 2032

Figure 24. Global Knee Denervation Sales Volume Market Share by Application, 2025 & 2032

Figure 25. Global Knee Denervation Price by Application (US$/Unit), 2021–2032

Figure 26. North America Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 27. North America Knee Denervation Sales Value by Country (%), 2025 vs 2032

Figure 28. Europe Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 29. Europe Knee Denervation Sales Value by Country (%), 2025 vs 2032

Figure 30. Asia Pacific Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 31. Asia Pacific Knee Denervation Sales Value by Region (%), 2025 vs 2032

Figure 32. South America Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 33. South America Knee Denervation Sales Value by Country (%), 2025 vs 2032

Figure 34. Middle East & Africa Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 35. Middle East & Africa Knee Denervation Sales Value by Country (%), 2025 vs 2032

Figure 36. Key Countries/Regions Knee Denervation Sales Value (%), 2021–2032

Figure 37. Key Countries/Regions Knee Denervation Sales Volume (%), 2021–2032

Figure 38. United States Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 39. United States Knee Denervation Sales Value by Type (%), 2025 vs 2032

Figure 40. United States Knee Denervation Sales Value by Application (%), 2025 vs 2032

Figure 41. Europe Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 42. Europe Knee Denervation Sales Value by Type (%), 2025 vs 2032

Figure 43. Europe Knee Denervation Sales Value by Application (%), 2025 vs 2032

Figure 44. China Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 45. China Knee Denervation Sales Value by Type (%), 2025 vs 2032

Figure 46. China Knee Denervation Sales Value by Application (%), 2025 vs 2032

Figure 47. Japan Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 48. Japan Knee Denervation Sales Value by Type (%), 2025 vs 2032

Figure 49. Japan Knee Denervation Sales Value by Application (%), 2025 vs 2032

Figure 50. South Korea Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 51. South Korea Knee Denervation Sales Value by Type (%), 2025 vs 2032

Figure 52. South Korea Knee Denervation Sales Value by Application (%), 2025 vs 2032

Figure 53. Southeast Asia Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 54. Southeast Asia Knee Denervation Sales Value by Type (%), 2025 vs 2032

Figure 55. Southeast Asia Knee Denervation Sales Value by Application (%), 2025 vs 2032

Figure 56. India Knee Denervation Sales Value (US$ Million), 2021–2032

Figure 57. India Knee Denervation Sales Value by Type (%), 2025 vs 2032

Figure 58. India Knee Denervation Sales Value by Application (%), 2025 vs 2032

Figure 59. Knee Denervation Industrial Chain

Figure 60. Knee Denervation Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Knee Denervation market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Knee Denervation market is 20.3% 2026 to 2032.

Which companies rank high in the global Knee Denervation market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Knee Denervation in 2026? shouQi

What was the global market size of Knee Denervation in 2032? shouQi

Related Reports

Global Knee Denervation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Knee Denervation market size was US$ 413 million in 2025 and is forecast to reach a readjusted size of US$ 1482 million by 2032 with a CAGR of 20.3% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 80
USD 4250.00
(Single User License)
Global Knee Denervation Market Research Report 2026
The global Knee Denervation market was valued at US$ 413 million in 2025 and is anticipated to reach US$ 1482 million by 2032, at a CAGR of 20.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 117
USD 2900.00
(Single User License)
Global Knee Denervation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Knee Denervation market size was US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
Published Date: 2025-09-11
Pages: 76
USD 4250.00
(Single User License)
Global Knee Denervation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Knee Denervation market is projected to grow from US$ 354 million in 2024 to US$ 1253 million by 2031, at a CAGR of 20.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-30
Pages: 137
USD 4900.00
(Single User License)
Global Knee Denervation Market Insights, Forecast to 2031
The global Knee Denervation market is projected to grow from US$ 413 million in 2025 to US$ 1253 million by 2031, at a Compound Annual Growth Rate (CAGR) of 20.3% during the forecast period.
Published Date: 2025-06-26
Pages: 129
USD 4900.00
(Single User License)
Knee Denervation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Knee Denervation was estimated to be worth US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
Published Date: 2025-06-26
Pages: 103
USD 3950.00
(Single User License)
Global Knee Denervation Market Research Report 2025
The global market for Knee Denervation was valued at US$ 354 million in the year 2024 and is projected to reach a revised size of US$ 1253 million by 2031, growing at a CAGR of 20.3% during the forecast period.
Published Date: 2025-06-26
Pages: 79
USD 2900.00
(Single User License)
Global Knee Denervation Market Research Report 2024
The global market for Knee Denervation was valued at US$ 309 million in the year 2023 and is projected to reach a revised size of US$ 1076 million by 2030, growing at a CAGR of 20.3% during the forecast period.
Published Date: 2024-12-29
Pages: 79
USD 2900.00
(Single User License)
Knee Denervation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Knee Denervation was estimated to be worth US$ 309 million in 2023 and is forecast to a readjusted size of US$ 1076 million by 2030 with a CAGR of 20.3% during the forecast period 2024-2030.
Published Date: 2024-12-29
Pages: 104
USD 3950.00
(Single User License)
Global Knee Denervation Market Insights, Forecast to 2030
Valued at US$ 355 million in 2024, the global Knee Denervation market is forecast to reach US$ 1076 million by 2030, at a CAGR of 20.3% during the forecast period.
Published Date: 2024-12-29
Pages: 127
USD 4900.00
(Single User License)

Global Knee Denervation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Knee Denervation market size was US$ 413 million in 2025 and is forecast to reach a readjusted size of US$ 1482 million by 2032 with a CAGR of 20.3% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 80
USD 4250.00 (Single User License)
Global Knee Denervation Market Research Report 2026
The global Knee Denervation market was valued at US$ 413 million in 2025 and is anticipated to reach US$ 1482 million by 2032, at a CAGR of 20.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 117
USD 2900.00 (Single User License)
Global Knee Denervation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Knee Denervation market size was US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
Published: 2025-09-11
Pages: 76
USD 4250.00 (Single User License)
Global Knee Denervation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Knee Denervation market is projected to grow from US$ 354 million in 2024 to US$ 1253 million by 2031, at a CAGR of 20.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-30
Pages: 137
USD 4900.00 (Single User License)
Global Knee Denervation Market Insights, Forecast to 2031
The global Knee Denervation market is projected to grow from US$ 413 million in 2025 to US$ 1253 million by 2031, at a Compound Annual Growth Rate (CAGR) of 20.3% during the forecast period.
Published: 2025-06-26
Pages: 129
USD 4900.00 (Single User License)
Knee Denervation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Knee Denervation was estimated to be worth US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
Published: 2025-06-26
Pages: 103
USD 3950.00 (Single User License)
Global Knee Denervation Market Research Report 2025
The global market for Knee Denervation was valued at US$ 354 million in the year 2024 and is projected to reach a revised size of US$ 1253 million by 2031, growing at a CAGR of 20.3% during the forecast period.
Published: 2025-06-26
Pages: 79
USD 2900.00 (Single User License)
Global Knee Denervation Market Research Report 2024
The global market for Knee Denervation was valued at US$ 309 million in the year 2023 and is projected to reach a revised size of US$ 1076 million by 2030, growing at a CAGR of 20.3% during the forecast period.
Published: 2024-12-29
Pages: 79
USD 2900.00 (Single User License)
Knee Denervation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Knee Denervation was estimated to be worth US$ 309 million in 2023 and is forecast to a readjusted size of US$ 1076 million by 2030 with a CAGR of 20.3% during the forecast period 2024-2030.
Published: 2024-12-29
Pages: 104
USD 3950.00 (Single User License)
Global Knee Denervation Market Insights, Forecast to 2030
Valued at US$ 355 million in 2024, the global Knee Denervation market is forecast to reach US$ 1076 million by 2030, at a CAGR of 20.3% during the forecast period.
Published: 2024-12-29
Pages: 127
USD 4900.00 (Single User License)